I recently was reading notes on the website of the American Society of Nephrology and came across an unfamiliar statement. These notes reference Theodore I. Steinman for the ASN Board Review, so this not information from an unreliable source. These conference cast notes on Polycystic Kidney Disease dated August 1, 2016, on page 15, under Management Issues, state “Avoid drugs that stimulate release of Vasopressin or potentiate its action –SSRI –TCA”. I have tried without success to find information in this regard. I would like to find literature specifically addressing the use of specific antidepressants in PKD patients. Any information you may be able to provide in this regard would be greatly appreciated.